Company news
JW (Cayman) Therapeutics Co. Ltd. news in 2025
JW (Cayman) Therapeutics Co. Ltd.'s news releases, calls and decks from 2025, newest first.
JW Therapeutics and Regeneron Expand Strategic Collaboration Agreement to Advance TCR-T Cell Therapy Development and Maximize Global Platform Potential
October 31, 2025
JW Therapeutics Announces Approval of Relmacabtagene Autoleucel Injection (Carteyva®) for Marketing in Macao
June 4, 2025
JW Therapeutics - Receipt of Breakthrough Therapy Designation for Carteyva in China as Second-line Treatment in Relapsed or Refractory adult Large B-cell Lymphoma
January 13, 2025
Decks in 2025
- FY2024 Earnings Presentation
Earnings · 13 slides · 2025
- JW Therapeutics — FY2024 Earnings Presentation
Earnings · 13 slides · 2025